Caris Life Sciences, Inc. Common Stock vs. Castle Biosciences, Inc. Common Stock
CAI
Caris Life Sciences, Inc. Common Stock
$29.98 -3.04%
VS CSTLCastle Biosciences, Inc. Common Stock
$35.75 -2.80%
Caris Life Sciences, Inc. Common Stock (CAI) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| CAI | CSTL | |
|---|---|---|
| Market Cap | $8.74 billion | $1.12 billion |
| Revenue (TTM) | $989.61 million | $357.28 million |
| Net Income (TTM) | $105.14 million | $-19,415,000 |
CAI leads on 3 of 3 size & scale factors.
Valuation
| CAI | CSTL | |
|---|---|---|
| P/E Ratio | 17.74 | — |
| Price / Book | 14.77 | 2.39 |
| Price / Sales | 8.83 | 3.14 |
CSTL leads on 2 of 2 valuation factors.
Profitability
| CAI | CSTL | |
|---|---|---|
| Net Margin | 10.62% | -5.43% |
| Return on Equity | 17.77% | -4.13% |
CAI leads on 2 of 2 profitability factors.
Dividend
| CAI | CSTL | |
|---|---|---|
| Dividend Yield | 4.00% | — |
| Payout Ratio | 71.01 | — |
CAI and CSTL split the dividend factors evenly.
Risk & Sentiment
| CAI | CSTL | |
|---|---|---|
| Short Interest | 0.13% | 0.04% |
CSTL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CAI overview, CAI financials, CSTL overview, CSTL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.